Rajkumar SV - Search Results

1

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

Gonsalves WI, Rajkumar SV, Gupta V, Morice WG, Timm MM, Singh PP, Dispenzieri A, Buadi FK, Lacy MQ, Kapoor P, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: rajkumar sv. Leukemia. 2014 Oct;28(10):2060-5. doi: 10.1038/leu.2014.98. Epub 2014 Mar 12. Leukemia. 2014. PMID: 24618735 Free PMC article.

2

IMWG consensus on risk stratification in multiple myeloma.

Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group. Chng WJ, et al. Leukemia. 2014 Feb;28(2):269-77. doi: 10.1038/leu.2013.247. Epub 2013 Aug 26. Leukemia. 2014. PMID: 23974982 Review.

3

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Among authors: rajkumar sv. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

4

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA, Kyle RA, Greipp PR, Gertz MA, Witzig TE. Rajkumar SV, et al. Leukemia. 2001 Aug;15(8):1274-6. doi: 10.1038/sj.leu.2402183. Leukemia. 2001. PMID: 11480571 Clinical Trial.

5

Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.

Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Rajkumar SV, et al. Am J Hematol. 2001 Dec;68(4):269-75. doi: 10.1002/ajh.10003. Am J Hematol. 2001. PMID: 11754416 Free article.

6

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.

Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Dávila R, González-Paz N, Winkler JM, Kyle RA, Gertz MA, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA, Greipp PR, Fonseca R. Debes-Marun CS, et al. Among authors: rajkumar sv. Leukemia. 2003 Feb;17(2):427-36. doi: 10.1038/sj.leu.2402797. Leukemia. 2003. PMID: 12592343

7

Thalidomide as initial therapy for early-stage myeloma.

Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Fonseca R, Geyer SM, Iturria N, Kumar S, Lust JA, Kyle RA, Greipp PR, Witzig TE. Rajkumar SV, et al. Leukemia. 2003 Apr;17(4):775-9. doi: 10.1038/sj.leu.2402866. Leukemia. 2003. PMID: 12682636 Clinical Trial.

8

Expression of VEGF and its receptors by myeloma cells.

Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Leukemia. 2003 Oct;17(10):2025-31. doi: 10.1038/sj.leu.2403084. Leukemia. 2003. PMID: 14513053

9

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

Kumar S, Witzig TE, Dispenzieri A, Lacy MQ, Wellik LE, Fonseca R, Lust JA, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Leukemia. 2004 Mar;18(3):624-7. doi: 10.1038/sj.leu.2403285. Leukemia. 2004. PMID: 14749707 Clinical Trial.

10

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R, Lust JA, Witzig TE, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Bone Marrow Transplant. 2004 Aug;34(3):235-9. doi: 10.1038/sj.bmt.1704555. Bone Marrow Transplant. 2004. PMID: 15170170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

798 results

Search Page